Abiomed Inc logo

ABMD - Abiomed Inc Share Price

$189.77 -0.1  -0.1%

Last Trade - 4:06pm

Sector
Healthcare
Size
Large Cap
Market Cap £6.58bn
Enterprise Value £6.24bn
Revenue £628.7m
Position in Universe 874th / 6416
Bullish
Bearish
Unlock ABMD Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ABMD Revenue Unlock ABMD Revenue

Net Income

ABMD Net Income Unlock ABMD Revenue

Normalised EPS

ABMD Normalised EPS Unlock ABMD Revenue

PE Ratio Range

ABMD PE Ratio Range Unlock ABMD Revenue

Dividend Yield Range

ABMD Dividend Yield Range Unlock ABMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ABMD EPS Forecasts Unlock ABMD Revenue
Profile Summary

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated June 4, 1987
Public Since July 29, 1987
No. of Shareholders: 422
No. of Employees: 1,371
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange NASDAQ Global Select Market
Shares in Issue 45,238,952
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABMD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ABMD
Upcoming Events for ABMD
Wednesday 29th January, 2020 Estimate
Q3 2020 Abiomed Inc Earnings Release
Thursday 6th February, 2020
Q3 2020 Abiomed Inc Earnings Call
Thursday 30th April, 2020 Estimate
Q4 2020 Abiomed Inc Earnings Release
Similar to ABMD
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.